Harnessing Cell Free Dna Testing To Combat Transplant Rejection Natera
Welcome back! In today's episode, Kent speaks with Shephalie, Michelle, and Mike from Michigan Medicine Cardiovascular Medicine Grand Rounds titled, “Clinical Applications of Third Annual Global Summit: Global Kidney Innovations - Expanding Patient Choices & Outcomes A collaborative partnership ... Presenter: Kiran Khush, MD Professor Director of Heart JoDee shares her experience using Prospera™ with her care team to inform her son's post-kidney Check out this case study and learn about the increased risk of
Two Thresholds, One Powerful Solution: Combining the Quantity and Fraction of dd-cfDNA in a Single Blood Armand Halter underwent a deceased donor kidney
How Does Cell Free DNA Testing Aid Heart Transplant Rejection Monitoring?
Dr Deshpande's pioneering research on
Episode 49: Kent Talks about Testing for Rejection with Shephalie, Michelle, and Mike from Natera
Welcome back! In today's episode, Kent speaks with Shephalie, Michelle, and Mike from
Molecular-level Insights in Kidney and Pancreas Transplant Care: Prospera Deep Dive
Satellite Symposium presented by
Natera CEO: We’re using DNA tech to change disease management
Jim Cramer chats with
Clinical Applications of Cell-Free DNA Testing After Heart Transplantation
Michigan Medicine Cardiovascular Medicine Grand Rounds titled, “Clinical Applications of
Natera: Revolutionizing healthcare with generation cell free DNA testing
Jane King interviews Steve Chapman, CEO,
Episode 101: Mala and Monica Discuss Prospera & Renasight
Kent begins a series of Podcasts with
Advancements in Cell-free DNA Testing to Improve Post-Transplant Care (Reginald Seeto)
Third Annual Global Summit: Global Kidney Innovations - Expanding Patient Choices & Outcomes A collaborative...
Clinical applications of cell-free DNA testing after transplantation
Presenter: Kiran Khush, MD Professor Director of Heart
Utilizing Cell-Free DNA Technologies
Pathology #OrganTransplant Donor-derived
JoDee & Daniel’s story | Prospera™ For kidney transplant assessment
JoDee shares her experience using Prospera™ with her care team to inform her son's post-kidney
Susan Gross, Natera: Identifying Constellations in CellFree DNA
Non-invasive prenatal
Why should you use genetic testing in living donors? Dr. Anil Chandraker discusses a case study
Check out this case study and learn about the increased risk of
Two Thresholds, One Powerful Solution Webinar Presented by Natera
Two Thresholds, One Powerful Solution: Combining the Quantity and Fraction of dd-cfDNA in a Single Blood
Episode 106: Armand Halter - A Journey with Prospera and Kidney Rejection
Armand Halter underwent a deceased donor kidney